Eliem Therapeutics, Inc
News
Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit
Globe Newswire SEATTLE and CAMBRIDGE, United Kingdom, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (Nasdaq: ELYM), announced today members of the management team will participate at the Stifel 2024...\n more…
Eliem Therapeutics (NASDAQ:ELYM) Trading Up 4.6%
Ticker Report Eliem Therapeutics, Inc. (NASDAQ:ELYM - Get Free Report) traded up 4.6% during trading on Thursday . The stock traded as high as $7.65 and last traded at $7.57. 321,772 shares traded hands during...\n more…
Eliem Therapeutics: Executive Changes Amid Strategic Shift
TipRanks Financial Blog Eliem Therapeutics (ELYM) just unveiled an update. Eliem Therapeutics, Inc. has undergone significant changes with Dr. Valerie Morisset's departure following the co...\n more…
Eliem Therapeutics appoints Kaplan as COO; Rampal as SVP, Clinical Development
SeekingAlpha.com: All News Eliem Therapeutics (ELYM) has announced the appointments of Brett Kaplan as COO and Nishi Rampal as Senior Vice President, Clinical Development. Most recently, Kaplan served as President and\n more…
Eliem Therapeutics Announces Additions to its Leadership Team
Globe Newswire Brett Kaplan, M.D. appointed Chief Operating Officer Nishi Rampal, M.D. appointed Senior Vice President, Clinical Development SEATTLE and CAMBRIDGE, United Kingdom, Aug. 26, 2024 (GLOBE...\n more…